# ERLOTINIB HYDROCHLORIDE
> **ANDA210300** · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM · Approved 2019-11-05
## Drug
- **FDA Application Number:** ANDA210300
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ERLOTINIB HYDROCHLORIDE
- **Generic name:** ERLOTINIB
- **Active ingredients:** ERLOTINIB HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SUN PHARM
- **Manufacturer:** Sun Pharmaceutical Industries, Inc.
- **First approval:** 2019-11-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210300)
---
*AI Analytics · CC0 1.0*